Cargando…

Reduction in circulating vitamin D binding protein in patients with multiple sclerosis

BACKGROUND: In this study, we aimed to determine the risk association between vitamin D binding protein (VDBP) polymorphism in patients with multiple sclerosis (MS) in a MS biobank and the difference in VDBP serum levels in MS patients who were recently diagnosed. METHOD: The current case-control st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maghbooli, Zhila, Omidifar, Abolfazl, Varzandi, Tarlan, Salehnezhad, Tayebeh, Sahraian, Mohammad Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056586/ https://www.ncbi.nlm.nih.gov/pubmed/33879066 http://dx.doi.org/10.1186/s12883-021-02200-0

Ejemplares similares

The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder
por: Maghbooli, Zhila, et al.
Publicado: (2021)

Role of Type 1 Interferons therapy on Adverse Clinical Outcomes on COVID-19 in Hospitalized Multiple Sclerosis Patients
por: Maghbooli, Zhila, et al.
Publicado: (2023)

Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection
por: Maghbooli, Zhila, et al.
Publicado: (2022)

Treatment With 25-Hydroxyvitamin D(3) (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
por: Maghbooli, Zhila, et al.
Publicado: (2021)

Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Alterations in circulating levels of vitamin D binding protein, total and bioavailability of vitamin D in diabetic retinopathy patients
por: Maghbooli, Zhila, et al.
Publicado: (2022)

Vitamin D and multiple sclerosis
por: Harandi, Asghar Amini, et al.
Publicado: (2014)

Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease
por: Emamgholipour, Solaleh, et al.
Publicado: (2013)

Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease
por: Emamgholipour, Solaleh, et al.
Publicado: (2013)

Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease
por: Emamgholipour, Solaleh, et al.
Publicado: (2014)

Interactions between vitamin D binding protein variants and major dietary patterns on the odds of metabolic syndrome and its components in apparently healthy adults
por: Rahimi, Mohammad Hossein, et al.
Publicado: (2019)

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Vitamin D status in mothers and their newborns in Iran
por: Maghbooli, Zhila, et al.
Publicado: (2007)

Iranian consensus on use of vitamin D in patients with multiple sclerosis
por: Jahromi, Soodeh Razeghi, et al.
Publicado: (2016)

Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls
por: Eskandari, Ghazaleh, et al.
Publicado: (2015)

The Role of Vitamin D Deficiency and Vitamin D Receptor Genotypes on the Degree of Collateralization in Patients with Suspected Coronary Artery Disease
por: Hossein-Nezhad, Arash, et al.
Publicado: (2014)

The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2019)

Prevalence of Multiple Sclerosis (MS) in Zanjan Province of Iran
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Circulating omentin-1 might be associated with metabolic health status in different phenotypes of body size
por: Alizadeh, Shahab, et al.
Publicado: (2017)

Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
por: Molazadeh, Negar, et al.
Publicado: (2023)

Effect of Vitamin D Supplements on Relapse Rate and Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
por: Hanaei, Sara, et al.
Publicado: (2021)

Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models
por: Hosseinnataj, Abolfazl, et al.
Publicado: (2023)

Vitamin D deficiency, bone turnover markers and causative factors among adolescents: a cross-sectional study
por: Larijani, Bagher, et al.
Publicado: (2016)

The prevalence of multiple sclerosis in Tehran, Iran, in 2020
por: Eskandarieh, Sharareh, et al.
Publicado: (2023)

Vitamin D receptor binding, chromatin states and association with multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2012)

Is it time to revise the classification of geographical distribution of multiple sclerosis?
por: Sahraian, Mohammad Ali, et al.
Publicado: (2012)

Vitamin D-Binding Protein Polymorphisms, 25-Hydroxyvitamin D, Sunshine and Multiple Sclerosis
por: Langer-Gould, Annette, et al.
Publicado: (2018)

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran
por: ESKANDARIEH, Sharareh, et al.
Publicado: (2017)

The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis
por: Jafarirad, Sima, et al.
Publicado: (2012)

Update in vitamin D and multiple sclerosis
por: Alharbi, Fatimah M.
Publicado: (2015)

Determinants of sexual dysfunction in women with multiple sclerosis
por: Mohammadi, Khadijeh, et al.
Publicado: (2013)

Clinical and demographic factors affecting disease severity in patients with multiple sclerosis
por: Baghizadeh, Somayeh, et al.
Publicado: (2013)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020)

Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran
por: Omrani, Mohammad Amin, et al.
Publicado: (2023)

Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

Air pollution during pregnancy and placental adaptation in the levels of global DNA methylation
por: Maghbooli, Zhila, et al.
Publicado: (2018)

The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis
por: Almasi, Mostafa, et al.
Publicado: (2021)

Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations
por: Halabchi, Farzin, et al.
Publicado: (2017)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c1jggr9l2ba0jjlot682vkpr7r